
Medistim ASA
OSE:MEDI

Medistim ASA
Long-Term Debt
Medistim ASA
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Medistim ASA
OSE:MEDI
|
Long-Term Debt
kr25.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
9%
|
|
![]() |
Lifecare AS
OSE:LIFE
|
Long-Term Debt
kr7.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Long-Term Debt
kr50m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

See Also
What is Medistim ASA's Long-Term Debt?
Long-Term Debt
25.1m
NOK
Based on the financial report for Dec 31, 2024, Medistim ASA's Long-Term Debt amounts to 25.1m NOK.
What is Medistim ASA's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
9%
Over the last year, the Long-Term Debt growth was 171%. The average annual Long-Term Debt growth rates for Medistim ASA have been 14% over the past three years , -2% over the past five years , and 9% over the past ten years .